Autopsy report · NCT01088334

Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism

“Terminated because of futility to continue, after planned interim analysis.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 years 2 months after it had already started.
• Ran for about 6 years before it stopped.
• 630 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Slotervaart Hospital

Sponsor type

University, hospital or other

Conditions

Venous Thromboembolism; Malignancy

Interventions

screening

Participants

630

Sites

10

Countries

Netherlands

Trials that died the same way

• Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients
  “terminated due to futility after interim analysis” (90% match in meaning)
• Plasmalyte Versus Saline in Trauma Patients
  “Premature termination due to futility following interim analysis” (80% match in meaning)
• Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
  “Terminated due to lack of efficacy” (76% match in meaning)
• A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma
  “Terminated due to safety concerns.” (75% match in meaning)
• Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
  “terminated due to administrative reasons.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.